![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 19, 2014 1:27:55 AM
SK3 owns the Co from a stock swap.
SK3 merge with AEGY that SK3 owns anyway.
AVNE from the stock swap gets: Aventura receiving the rights to the intellectual property in the proprietary technology, processes, formulations, and marks of Berkeley Bio that have already been developed,
So SK3 owns all the stuff anyway, meaning it can figure who gets how much money from what.
If SK3 thinks having AVNE showing income from proprietary technology, processes, formulations, and marks of Berkeley Bio that have already been developed, then the stock has value. If SK3 says no value thetre then why the foward split and ticker?
on sale. Buy when when everyone else is selling.
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM